The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients
Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine. Original article, literature search. Several members of the original t...
Gespeichert in:
| Veröffentlicht in: | Critical care medicine 2021-04, Vol.49 (4), p.623-635 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 635 |
|---|---|
| container_issue | 4 |
| container_start_page | 623 |
| container_title | Critical care medicine |
| container_volume | 49 |
| creator | Lat, Ishaq Coopersmith, Craig M. De Backer, Daniel |
| description | Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
Original article, literature search.
Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
None.
None.
In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research. |
| doi_str_mv | 10.1097/CCM.0000000000004864 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7963440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2502809075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4536-8f2d03f5d044062ddbcb86572df93039884b6b5ff974c4424942a463eac0d5573</originalsourceid><addsrcrecordid>eNpdkV1v1SAcxonRuOP0GxjDpTfd_uWtxQuTpXFuycwWN70lFOgp2lM6aM-yby_HvbjJDQGe5_cAD0LvSzgoQVaHTfPtAJ4MVgv2Aq1KTqEAIulLtAKQUFAm6R56k9IvgJLxir5Ge5RWtBRQrdB01Tt8ucSt3_pxjS_dlHzCjd5M2q_HT_h4WLzF311akvGznn0YsR4t_qlTmKJLKUScEVFPtzuV09H0-CL6EP3sXcJ-xEd2GWZ8kb1unNNb9KrTQ3Lv7ud99OP4y1VzUpydfz1tjs4KwzgVRd0RC7TjFhgDQaxtTVsLXhHbSQpU1jVrRcu7TlbMMEaYZEQzQZ02YHl-5T76fMedlnbjrMnZUQ9qin6j460K2qvnJ6Pv1TpsVSUFzZkZ8PEeEMP14tKsNj4ZNwx6dGFJinAgdf7gimcpu5OaGFKKrnuMKUHtylK5LPV_Wdn24ekVH00P7fzj3oRhdjH9HpYbF1Xv9DD3f3mUMFEQICWwvCp2W4L-ASsDoO0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2502809075</pqid></control><display><type>article</type><title>The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Lat, Ishaq ; Coopersmith, Craig M. ; De Backer, Daniel</creator><creatorcontrib>Lat, Ishaq ; Coopersmith, Craig M. ; De Backer, Daniel ; Manhasset, NY ; Utrecht, the Netherlands ; San Francisco, CA ; Consultant, London, United Kingdom ; Consultant, Seattle, WA ; Atlanta, GA ; Pune, India ; Sao Paulo, Brazil ; Chicago, IL ; Barcelona, Spain ; Co-chair, Atlanta, GA ; Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Seattle, WA and Barcelona, Spain and San Francisco, CA and Pune, India and Utrecht, the Netherlands and Chicago, IL and Sao Paulo, Brazil and Atlanta, GA and Dublin, Ireland and New York, NY and Consultant, London, United Kingdom ; New York, NY ; Co-chair, Brussels, Belgium ; Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows ; Dublin, Ireland ; Research Committee of the Surviving Sepsis Campaign</creatorcontrib><description>Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
Original article, literature search.
Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
None.
None.
In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.</description><identifier>ISSN: 0090-3493</identifier><identifier>ISSN: 1530-0293</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/CCM.0000000000004864</identifier><identifier>PMID: 33731607</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Adult ; Critical Care - methods ; Evidence-Based Medicine ; Female ; Fluid Therapy - methods ; Guidelines as Topic ; Humans ; Male ; Practice Guidelines as Topic ; Sepsis - therapy ; Severity of Illness Index ; The Surviving Sepsis Campaign ; Vasoconstrictor Agents - therapeutic use</subject><ispartof>Critical care medicine, 2021-04, Vol.49 (4), p.623-635</ispartof><rights>Lippincott Williams & Wilkins</rights><rights>Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4536-8f2d03f5d044062ddbcb86572df93039884b6b5ff974c4424942a463eac0d5573</citedby><cites>FETCH-LOGICAL-c4536-8f2d03f5d044062ddbcb86572df93039884b6b5ff974c4424942a463eac0d5573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33731607$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lat, Ishaq</creatorcontrib><creatorcontrib>Coopersmith, Craig M.</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Manhasset, NY</creatorcontrib><creatorcontrib>Utrecht, the Netherlands</creatorcontrib><creatorcontrib>San Francisco, CA</creatorcontrib><creatorcontrib>Consultant, London, United Kingdom</creatorcontrib><creatorcontrib>Consultant, Seattle, WA</creatorcontrib><creatorcontrib>Atlanta, GA</creatorcontrib><creatorcontrib>Pune, India</creatorcontrib><creatorcontrib>Sao Paulo, Brazil</creatorcontrib><creatorcontrib>Chicago, IL</creatorcontrib><creatorcontrib>Barcelona, Spain</creatorcontrib><creatorcontrib>Co-chair, Atlanta, GA</creatorcontrib><creatorcontrib>Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Seattle, WA and Barcelona, Spain and San Francisco, CA and Pune, India and Utrecht, the Netherlands and Chicago, IL and Sao Paulo, Brazil and Atlanta, GA and Dublin, Ireland and New York, NY and Consultant, London, United Kingdom</creatorcontrib><creatorcontrib>New York, NY</creatorcontrib><creatorcontrib>Co-chair, Brussels, Belgium</creatorcontrib><creatorcontrib>Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows</creatorcontrib><creatorcontrib>Dublin, Ireland</creatorcontrib><creatorcontrib>Research Committee of the Surviving Sepsis Campaign</creatorcontrib><title>The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
Original article, literature search.
Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
None.
None.
In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.</description><subject>Adult</subject><subject>Critical Care - methods</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Fluid Therapy - methods</subject><subject>Guidelines as Topic</subject><subject>Humans</subject><subject>Male</subject><subject>Practice Guidelines as Topic</subject><subject>Sepsis - therapy</subject><subject>Severity of Illness Index</subject><subject>The Surviving Sepsis Campaign</subject><subject>Vasoconstrictor Agents - therapeutic use</subject><issn>0090-3493</issn><issn>1530-0293</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkV1v1SAcxonRuOP0GxjDpTfd_uWtxQuTpXFuycwWN70lFOgp2lM6aM-yby_HvbjJDQGe5_cAD0LvSzgoQVaHTfPtAJ4MVgv2Aq1KTqEAIulLtAKQUFAm6R56k9IvgJLxir5Ge5RWtBRQrdB01Tt8ucSt3_pxjS_dlHzCjd5M2q_HT_h4WLzF311akvGznn0YsR4t_qlTmKJLKUScEVFPtzuV09H0-CL6EP3sXcJ-xEd2GWZ8kb1unNNb9KrTQ3Lv7ud99OP4y1VzUpydfz1tjs4KwzgVRd0RC7TjFhgDQaxtTVsLXhHbSQpU1jVrRcu7TlbMMEaYZEQzQZ02YHl-5T76fMedlnbjrMnZUQ9qin6j460K2qvnJ6Pv1TpsVSUFzZkZ8PEeEMP14tKsNj4ZNwx6dGFJinAgdf7gimcpu5OaGFKKrnuMKUHtylK5LPV_Wdn24ekVH00P7fzj3oRhdjH9HpYbF1Xv9DD3f3mUMFEQICWwvCp2W4L-ASsDoO0</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Lat, Ishaq</creator><creator>Coopersmith, Craig M.</creator><creator>De Backer, Daniel</creator><general>Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210401</creationdate><title>The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients</title><author>Lat, Ishaq ; Coopersmith, Craig M. ; De Backer, Daniel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4536-8f2d03f5d044062ddbcb86572df93039884b6b5ff974c4424942a463eac0d5573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Critical Care - methods</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Fluid Therapy - methods</topic><topic>Guidelines as Topic</topic><topic>Humans</topic><topic>Male</topic><topic>Practice Guidelines as Topic</topic><topic>Sepsis - therapy</topic><topic>Severity of Illness Index</topic><topic>The Surviving Sepsis Campaign</topic><topic>Vasoconstrictor Agents - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lat, Ishaq</creatorcontrib><creatorcontrib>Coopersmith, Craig M.</creatorcontrib><creatorcontrib>De Backer, Daniel</creatorcontrib><creatorcontrib>Manhasset, NY</creatorcontrib><creatorcontrib>Utrecht, the Netherlands</creatorcontrib><creatorcontrib>San Francisco, CA</creatorcontrib><creatorcontrib>Consultant, London, United Kingdom</creatorcontrib><creatorcontrib>Consultant, Seattle, WA</creatorcontrib><creatorcontrib>Atlanta, GA</creatorcontrib><creatorcontrib>Pune, India</creatorcontrib><creatorcontrib>Sao Paulo, Brazil</creatorcontrib><creatorcontrib>Chicago, IL</creatorcontrib><creatorcontrib>Barcelona, Spain</creatorcontrib><creatorcontrib>Co-chair, Atlanta, GA</creatorcontrib><creatorcontrib>Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Seattle, WA and Barcelona, Spain and San Francisco, CA and Pune, India and Utrecht, the Netherlands and Chicago, IL and Sao Paulo, Brazil and Atlanta, GA and Dublin, Ireland and New York, NY and Consultant, London, United Kingdom</creatorcontrib><creatorcontrib>New York, NY</creatorcontrib><creatorcontrib>Co-chair, Brussels, Belgium</creatorcontrib><creatorcontrib>Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows</creatorcontrib><creatorcontrib>Dublin, Ireland</creatorcontrib><creatorcontrib>Research Committee of the Surviving Sepsis Campaign</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lat, Ishaq</au><au>Coopersmith, Craig M.</au><au>De Backer, Daniel</au><aucorp>Manhasset, NY</aucorp><aucorp>Utrecht, the Netherlands</aucorp><aucorp>San Francisco, CA</aucorp><aucorp>Consultant, London, United Kingdom</aucorp><aucorp>Consultant, Seattle, WA</aucorp><aucorp>Atlanta, GA</aucorp><aucorp>Pune, India</aucorp><aucorp>Sao Paulo, Brazil</aucorp><aucorp>Chicago, IL</aucorp><aucorp>Barcelona, Spain</aucorp><aucorp>Co-chair, Atlanta, GA</aucorp><aucorp>Research Committee of the Surviving Sepsis Campaign and Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows and Co-chair, Atlanta, GA and Co-chair, Brussels, Belgium and Manhasset, NY and Consultant, Seattle, WA and Barcelona, Spain and San Francisco, CA and Pune, India and Utrecht, the Netherlands and Chicago, IL and Sao Paulo, Brazil and Atlanta, GA and Dublin, Ireland and New York, NY and Consultant, London, United Kingdom</aucorp><aucorp>New York, NY</aucorp><aucorp>Co-chair, Brussels, Belgium</aucorp><aucorp>Members of the Surviving Sepsis Campaign Research Committee contributing to this article are as follows</aucorp><aucorp>Dublin, Ireland</aucorp><aucorp>Research Committee of the Surviving Sepsis Campaign</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>49</volume><issue>4</issue><spage>623</spage><epage>635</epage><pages>623-635</pages><issn>0090-3493</issn><issn>1530-0293</issn><eissn>1530-0293</eissn><abstract>Expand upon the priorities of fluid resuscitation and vasopressor therapy research priorities identified by a group of experts assigned by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine.
Original article, literature search.
Several members of the original task force with expertise specific to the area of fluid resuscitation and vasopressor therapy.
None.
None.
In the second of a series of manuscripts subsequent to the original article, members with expertise in the subjects expound upon the three identified priorities related to fluid resuscitation and vasopressor therapies. This analysis summarizes what is known and what were identified as ongoing and future research.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>33731607</pmid><doi>10.1097/CCM.0000000000004864</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-3493 |
| ispartof | Critical care medicine, 2021-04, Vol.49 (4), p.623-635 |
| issn | 0090-3493 1530-0293 1530-0293 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7963440 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult Critical Care - methods Evidence-Based Medicine Female Fluid Therapy - methods Guidelines as Topic Humans Male Practice Guidelines as Topic Sepsis - therapy Severity of Illness Index The Surviving Sepsis Campaign Vasoconstrictor Agents - therapeutic use |
| title | The Surviving Sepsis Campaign: Fluid Resuscitation and Vasopressor Therapy Research Priorities in Adult Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A30%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Surviving%20Sepsis%20Campaign:%20Fluid%20Resuscitation%20and%20Vasopressor%20Therapy%20Research%20Priorities%20in%20Adult%20Patients&rft.jtitle=Critical%20care%20medicine&rft.au=Lat,%20Ishaq&rft.aucorp=Manhasset,%20NY&rft.date=2021-04-01&rft.volume=49&rft.issue=4&rft.spage=623&rft.epage=635&rft.pages=623-635&rft.issn=0090-3493&rft.eissn=1530-0293&rft_id=info:doi/10.1097/CCM.0000000000004864&rft_dat=%3Cproquest_pubme%3E2502809075%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2502809075&rft_id=info:pmid/33731607&rfr_iscdi=true |